| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |